STOCK TITAN
  1. Home
  2. Sec-filings
  3. DRTS
  4. [Form 3] Alpha Tau Medical Ltd. Initial Statement of Beneficial Ownership

Alpha Tau Medical (NASDAQ: DRTS) director details initial equity holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. director Netser Maya filed an initial ownership report detailing current equity interests in the company. The filing shows direct ownership of 3,086 ordinary shares.

Maya also holds restricted share units representing 4,321 ordinary shares that vest in equal monthly installments over three years commencing on December 17, 2024, subject to continued service. An additional 4,680 restricted share units will vest in full upon the earlier of one year from March 9, 2026 or the next Annual General Meeting of Shareholders, also conditioned on continued service.

The report lists stock options to acquire 24,048 ordinary shares at an exercise price of $4.05 per share, vesting in equal monthly installments over three years commencing December 17, 2024, and expiring on January 22, 2035. Further options cover 15,527 ordinary shares at an exercise price of $6.41 per share, vesting in full upon the earlier of one year from March 9, 2026 or the next Annual General Meeting of Shareholders, with an expiration date of March 9, 2036.

Positive

  • None.

Negative

  • None.
Insider Netser Maya
Role Director
Type Security Shares Price Value
holding Options -- -- --
holding Options -- -- --
holding Ordinary Shares -- -- --
holding Restricted Share Units -- -- --
holding Restricted Share Units -- -- --
Holdings After Transaction: Options — 24,048 shares (Direct); Ordinary Shares — 3,086 shares (Direct); Restricted Share Units — 4,321 shares (Direct)
Footnotes (1)
  1. These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in monthly equal installments for a period of three years commencing December 17, 2024, subject to the Reporting Person's continued service. These ordinary shares represent restricted share units, which will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service. These are options to acquire ordinary shares, which options will vest in monthly equal installments for a period of three years commencing December 17, 2024, subject to the Reporting Person's continued service. These are options to acquire ordinary shares, which options will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding Insider Trading Forms →

FAQ

What does Alpha Tau Medical (DRTS) director Netser Maya report owning in this Form 3?
Netser Maya reports direct ownership of 3,086 ordinary shares of Alpha Tau Medical. The filing also lists multiple restricted share unit awards and stock options that, if vested and exercised, would increase equity exposure to the company.

How many restricted share units does Netser Maya hold in Alpha Tau Medical (DRTS)?
Netser Maya holds restricted share units representing 4,321 ordinary shares vesting monthly over three years from December 17, 2024, plus 4,680 restricted share units that vest in full upon the earlier of one year from March 9, 2026 or the next shareholder meeting.

What stock options are reported by Netser Maya in Alpha Tau Medical (DRTS)?
Maya reports options over 24,048 ordinary shares at an exercise price of $4.05 expiring January 22, 2035, and additional options over 15,527 ordinary shares at $6.41 expiring March 9, 2036, all subject to stated vesting conditions.

Are there any buy or sell transactions in this Alpha Tau Medical (DRTS) Form 3?
The Form 3 shows holdings only and no reported purchases or sales. It serves as an initial statement of beneficial ownership for director Netser Maya, listing existing shares, restricted share units, and stock options with their vesting terms.

How do Netser Maya’s restricted share units in Alpha Tau Medical (DRTS) vest?
One RSU grant representing 4,321 ordinary shares vests in equal monthly installments over three years from December 17, 2024. Another grant of 4,680 RSUs vests entirely upon the earlier of one year from March 9, 2026 or the next Annual General Meeting, assuming continued service.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Netser Maya
(Last)(First)(Middle)
C/O ALPHA TAU MEDICAL
PO BOX 45044
(Street)
JERUSALEM9777605
(City)(State)(Zip)
UNITED STATES
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026		3. Issuer Name and Ticker or Trading Symbol
Alpha Tau Medical Ltd. [ DRTS ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares3,086D
Restricted Share Units(1)4,321D
Restricted Share Units(2)4,680D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Options(3)01/17/202501/22/2035Ordinary Shares24,048$4.05D
Options(4) (4)03/09/2036Ordinary Shares15,527$6.41D
Explanation of Responses:
1. These ordinary shares represent the unvested portion of a grant of restricted share units, which vests in monthly equal installments for a period of three years commencing December 17, 2024, subject to the Reporting Person's continued service.
2. These ordinary shares represent restricted share units, which will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
3. These are options to acquire ordinary shares, which options will vest in monthly equal installments for a period of three years commencing December 17, 2024, subject to the Reporting Person's continued service.
4. These are options to acquire ordinary shares, which options will vest in their entirety upon the earlier of: one year commencing from March 9, 2026 or the next Annual General Meeting of Shareholders, subject to the Reporting Person's continued service.
/s/ Maya Racine Netser03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR